V. Cagno

Discipline

Economies et finances (1)

Type de document

Articles (6)

Co-auteur

Date

Source

Mot-clé

Human beings (5) virus (4) RNA (4) Development (3) Treatment (3) tissu (corporel) (2) thérapie (2) espèce (2) spectacle (2) protéine (2) intérêts (2) infection (2) Testing (2) Viruses (2) Therapeutics (2) Testing (2) Species (2) Molecules (2) Interest (2) Influenza (2) Infection (2) Expression (2) Cells (2) Cell lines (2) Animals (2) Ability (2) Receptors (2) Viruses (2) Use (2) Mechanism of action (2)

Documents écrit par V. Cagno (6) | parle de V. Cagno (0)

Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed -1 ribosomal frameshifting.
C. Varricchio et al.
Lignin: A Sustainable Antiviral Coating Material.
A. Boarino et al. (24 oct. 2022)
An anti-influenza combined therapy assessed by single cell RNA-sequencing.
C. Medaglia et al. (10 oct. 2022)
Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro.
V. Cagno et al. (12 juil. 2021)
Clinical severe acute respiratory syndrome coronavirus 2 isolation and antiviral testing.
G. Mathez et al. (2021)
A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism.
E.D. Tseligka et al.